Neurology Alert – March 1, 2007
March 1, 2007
View Issues
-
Status Epilepticus in Cancer Patients: Does It Make a Difference If the Tumor is a Primary Brain Tumor or Systemic Metastasis?
Status epilepticus, in the setting of cancer, is treatable and does not appear to increase mortality above the risk of the underlying disease. -
Neonatal MRI as Predictor of Neurodevelopmental Outcome in Preterm Infants
This article reports a strong correlation between abnormal MRI at term equivalent in preterm infants with adverse neurodevelopmental outcomes at 2 years of age, suggesting its utility for risk stratification. -
Prognostic Predictors in ALS
Faster progression of ALS is predicted by older age, presentation with bulbar signs, or presentation with distal limb muscle weakness. -
Low Vitamin D Levels May Increase Risk of Developing MS
Vitamin D supplementation may lower the risk of developing multiple sclerosis. -
Dystonia and the Long Distance Runner
This case series describes clinical features and treatment responses of an unusual focal leg action dystonia in 5 long distance runners. -
Lipoprotein(a) and Ischemic Stroke Risk: Who is At Risk?
Lipoprotein(a) is a low density lipoprotein that is implicated in atherosclerotic cerebrovascular disease. Elevated levels of Lp(a) appear to confer an increased risk of ischemic stroke. -
Pharmacology Watch
Aggressive statin therapy is associated with slowed progression and even regression of atherosclerosis. A new study suggests that, when monitoring statin therapy, increases in HDL cholesterol may be as important as decreases in LDL cholesterol in preventing disease progression. -
Clinical Briefs in Primary Care Supplement